Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures.

Literature DB >> 4624213

Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures.

Abstract

A comparative study was made of Formalin-inactivated Chikungunya vaccines prepared from the virus propagated in African green monkey kidney monolayers and concentrated chick embryo suspension cultures. The vaccine prepared in the chick embryo suspension cultures was significantly more protective to mice against a live homologous virus challenge and stimulated the production of 4 to 5 times more circulating antibodies than the vaccine prepared with virus grown in African green monkey kidney monolayer cultures.

Entities: Chemical Species

Mesh：

Substances：

Year: 1972 PMID： 4624213 PMCID： PMC380477 DOI： 10.1128/am.23.5.951-952.1972

Source DB: PubMed Journal: Appl Microbiol ISSN： 0003-6919

11 in total

1. ENHANCEMENT OF CHIKUNGUNYA VIRUS REPLICATION AND INHIBITION OF INTERFERON PRODUCTION BY ACTINOMYCIN D.

Authors: E HELLER
Journal: Virology Date: 1963-12 Impact factor: 3.616

2. AN EPIDEMIC OF CHIKUNGUNYA IN SOUTH-EASTERN SOUTHERN RHODESIA.

Authors: B M MCINTOSH; R M HARWIN; H E PATERSON; M L WESTWATER
Journal: Cent Afr J Med Date: 1963-09

3. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology.

Authors: W H LUMSDEN
Journal: Trans R Soc Trop Med Hyg Date: 1955-01 Impact factor: 2.184

4. A laboratory technique for studying the insect transmission of animal viruses, employing a bat-wing membrane, demonstrated with two African viruses.

Authors: R W ROSS
Journal: J Hyg (Lond) Date: 1956-06

5. Cytoplasmic RNA synthesis and viral antigen in FL cells infected with Chikungunya virus.

Authors: M Mantani; A Igarashi; P Tuchinda; S Kato
Journal: Biken J Date: 1967-12

6. Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues.

Authors: V R Harrison; L N Binn; R Randall
Journal: Am J Trop Med Hyg Date: 1967-11 Impact factor: 2.345

7. Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.

Authors: A White; S Berman; J P Lowenthal
Journal: Appl Microbiol Date: 1971-11

8. Growth of chikungunya virus in baby hamster kidney cell (BHK-21-clone 13) suspension cultures.

Authors: J L Davis; H M Hodge; W E Campbell
Journal: Appl Microbiol Date: 1971-02

9. Electron microscope study of development of Chikungunya virus in green monkey kidney stable (VERO) cells.

Authors: N Higashi; A Matsumoto; K Tabata; Y Nagatomo
Journal: Virology Date: 1967-09 Impact factor: 3.616

10. Chikungunya virus vaccine prepared by Tween-ether extraction.

Authors: K H Eckels; V R Harrison; F M Hetrick
Journal: Appl Microbiol Date: 1970-02

14 in total

1. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors: Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal: J Virol Date: 2014-01-08 Impact factor: 5.103

Review 2. Development of Vaccines for Chikungunya Fever.

Authors: Jesse H Erasmus; Shannan L Rossi; Scott C Weaver
Journal: J Infect Dis Date: 2016-12-15 Impact factor: 5.226

3. Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.

Authors: Adam D DeZure; Nina M Berkowitz; Barney S Graham; Julie E Ledgerwood
Journal: J Infect Dis Date: 2016-12-15 Impact factor: 5.226

Review 4. Vaccine and Therapeutic Options To Control Chikungunya Virus.

Authors: Ann M Powers
Journal: Clin Microbiol Rev Date: 2017-12-13 Impact factor: 26.132

5. A chikungunya fever vaccine utilizing an insect-specific virus platform.

Authors: Jesse H Erasmus; Albert J Auguste; Jason T Kaelber; Huanle Luo; Shannan L Rossi; Karla Fenton; Grace Leal; Dal Y Kim; Wah Chiu; Tian Wang; Ilya Frolov; Farooq Nasar; Scott C Weaver
Journal: Nat Med Date: 2016-12-19 Impact factor: 53.440

6. A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis.

Authors: Danher Wang; Andreas Suhrbier; Adam Penn-Nicholson; Jan Woraratanadharm; Joy Gardner; Min Luo; Thuy T Le; Itaru Anraku; Michael Sakalian; David Einfeld; John Y Dong
Journal: Vaccine Date: 2011-02-12 Impact factor: 3.641

Review 7. Chikungunya virus and prospects for a vaccine.

Authors: Scott C Weaver; Jorge E Osorio; Jill A Livengood; Rubing Chen; Dan T Stinchcomb
Journal: Expert Rev Vaccines Date: 2012-09 Impact factor: 5.217

8. Prime-boost immunization strategies against Chikungunya virus.

Authors: David Hallengärd; Fok-Moon Lum; Beate M Kümmerer; Aleksei Lulla; Valeria Lulla; Juan García-Arriaza; John K Fazakerley; Pierre Roques; Roger Le Grand; Andres Merits; Lisa F P Ng; Mariano Esteban; Peter Liljeström
Journal: J Virol Date: 2014-09-10 Impact factor: 5.103

Review 9. Replication cycle of chikungunya: a re-emerging arbovirus.

Authors: Maxime Solignat; Bernard Gay; Stephen Higgs; Laurence Briant; Christian Devaux
Journal: Virology Date: 2009-09-04 Impact factor: 3.616

10. Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate.

Authors: Kenneth S Plante; Shannan L Rossi; Nicholas A Bergren; Robert L Seymour; Scott C Weaver
Journal: PLoS Negl Trop Dis Date: 2015-09-04